top of page

SPRAVATO® Now at Three Strand Wellness

Spravato is at the forefront of therapies and is being praised for its effectivenessIt regulates feelings of happiness and sadness, and is initially given twice a week for our weeks, then less frequently in maintenance doses.


If you’ve taken two or more oral antidepressants and still experience symptoms of depression, you might have treatment-resistant depression (TRD).

It might be time to talk with us about a different treatment approach. See what makes SPRAVATO® different and learn more about other patients’ experiences with SPRAVATO®.

Adults with treatment-resistant depression who were part of a clinical study were given either a nasal esketamine spray or a placebo spray.

Those who added esketamine, the active ingredient in SPRAVATO®, to their oral antidepressant experienced a greater reduction of depressive symptoms at four weeks compared to those who received placebo plus an oral antidepressant.*

*Based on an overall score on a standardized rating scale.

bottom of page